Can I Buy Edwards Lifesciences Corp Shares in India?

Yes, Edwards Lifesciences Corp shares can be bought in India by opening an international trading account with Groww.

How to Buy Edwards Lifesciences Corp Shares in India?

One can easily invest in Edwards Lifesciences Corp shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Edwards Lifesciences Corp shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Edwards Lifesciences Corp.

What is the Share Price of Edwards Lifesciences Corp?

The share price of Edwards Lifesciences Corp is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Edwards Lifesciences Corp share price is $74.00 as of 12 Dec ‘24

What is the Market Cap of Edwards Lifesciences Corp?

The Edwards Lifesciences Corp market cap is $43.53B as of 12 Dec ‘24

What is the PE and PB ratio of Edwards Lifesciences Corp?

The PE and PB ratio of Edwards Lifesciences Corp is 10.5 and 4.6 as of 12 Dec ‘24

Edwards Lifesciences Corp Share Price, EW Stock Price Quote Today

<img alt="Edwards Lifesciences Corp" srcSet="https://assets-netstorage.groww.in/intl-stocks/logos/EW.png 1x, https://assets-netstorage.groww.in/intl-stocks/logos/EW.png 2x" src="https://assets-netstorage.groww.in/intl-stocks/logos/EW.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Edwards Lifesciences Corp Healthcare 
$74.00
+0.19(0.26%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$73.27$73.813,852,2824,854,238
FundamentalsMarket Cap$43.53B
P/B Ratio4.6
P/E Ratio10.5
Enterprise Value$40.56B
Div. Yield0.00%
Book Value10.97
EPS(TTM)2.35
ROE23.10%
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyHeadquartered in Irvine, California, Edwards Lifesciences Corporation is a medical technology company. It has over 13,900 employees that work in over 40 operations across the world. Some of the countries it operates in include Mexico, Ireland, Greece, Korea, Canada, Japan, India, Colombia, Portugal, Sweden, Italy, etc. This company is a global leader in the field of cardiac valves and hemodynamic monitoring. 
The company offers therapies, speciality teams and medical devices to its customer from around the world. It offers therapies of seven types, including clot management, hypotension management, Aortic Stenosis, shock management, enhanced surgical recovery and blood conservation. It has speciality teams under five categories, including, Surgical Team, TAVI Heart team, Anaesthesia, Hospital Administration and Critical Care team. 
Edwards also offers an array of medical devices under nine different categories namely vascular catheters, pressure monitoring, surgical valve replacement, hemodynamic monitoring, transcatheter heart valves, devices support software, pressure monitoring, transcatheter valve repair, accessories & instruments and surgical valve repair. Its most renowned product is the SAPIEN transcatheter aortic valve that is developed with the help of cow tissues. 
As of 2020, it is an S&P 500 component that has been recognised by prestigious organisations like Forbes and Fortune. It is the 613th company in the 2020 Fortune 1000 list and 1006th company in the 2020 Forbes Global 2000 list. Forbes has also recognized Edwards in its 2021 list of Just Companies. It trades in the New York Stock Exchange under the ticker symbol EW since 2000. The advent of Edwards Lifesciences dates back to 1958 when Miles Lowell Edwards was building the first artificial heart. He was in his 60s and had just retired from engineering with about 63 patents from several sectors under him. His knack towards healing a sick heart developed due to his own childhood experience with heart issues. He presented his concept of mechanising heart to an Oregon Medical School doctor name Dr Albert Starr. Soon Edwards Laboratories was established, and later got acquired by American Hospital Supply Corporation, changing its name to American Edwards Laboratories. 
In 1985, Baxter acquired American Edwards and spun it off as an independent publicly-held company in 2000, as Edwards Lifesciences. Between 2017 and 2019, the company has acquired Valtech Cardio at $340 million, Harpoon Medical at $100 million and CAS Medical Systems at approximately $100 million.  To make any investment, one must be aware of company details they are investing in.;
OrganisationEdwards Lifesciences Corp
IndustryMedical Devices
HeadQuartersIrvine, CA
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$73.27	$73.81	3,852,282	4,854,238

Market Cap	$43.53B
P/B Ratio	4.6
P/E Ratio	10.5
Enterprise Value	$40.56B

Organisation	Edwards Lifesciences Corp
Industry	Medical Devices
HeadQuarters	Irvine, CA